Hyperammonemic crises can be avoided in individuals with NAGS deficiency by the administration of carbamylglutamate (also known as carglumic acid), which activates carbamoyl phosphatase synthetase 1 (CPS1). This evidence concerns the gene CPS1 and hyperinsulinemic hypoglycemia, familial, 4.